Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 52.5% to $0.7050 in pre-market trading after jumping over 72% on Friday.
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock moved upwards by 68.1% to $6.59 during Tuesday’s after-market session. Kala Pharmaceuticals’s trading…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers IsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday’s regular session. Trading volume for IsoPlexis’s…
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.
SVB Leerink Maintains Outperform on Mereo BioPharma Group, Lowers Price Target to $4
SVB Leerink analyst Joseph Schwartz maintains Mereo BioPharma Group (NASDAQ:MREO) with a Outperform and lowers the price target from $8 to $4.
Mereo BioPharma Reaches Cooperation Agreement With Rubric Capital Management
Mereo to Appoint Four New Directors to its Board of Directors
Rubric has Withdrawn its General Meeting Requisition Notice and Related Proposals; Agrees to Standstill Provision Through Mereo's 2024 Annual
Mereo BioPharma Offered To Settle Proxy Contest With Rubric Capital Management By Putting Rubric Principal And Second New Director On The Board
Rubric Summarily Rejected the Proposal and Refused to Provide a Counteroffer
Rubric's Second General Meeting Requisition Notice Again Fails to Satisfy Basic Requirements
of the Companies Act 2006 Which Apply
Cantor Fitzgerald Initiates Coverage On Mereo BioPharma Group with Overweight Rating, Announces Price Target of $4
Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Mereo BioPharma Group (NASDAQ:MREO) with a Overweight rating and announces Price Target of $4.
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Gainers
Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.